×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TXG – 10x genomics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TXG
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/20
03:14 am
txg
10x Genomics, Inc. (TXG) Stock [Seeking Alpha]
Medium
Report
10x Genomics, Inc. (TXG) Stock [Seeking Alpha]
3/11
06:50 am
txg
2 Reasons to Sell TXG and 1 Stock to Buy Instead [Yahoo! Finance]
Low
Report
2 Reasons to Sell TXG and 1 Stock to Buy Instead [Yahoo! Finance]
3/8
01:33 am
txg
10x Genomics, Inc. (NASDAQ: TXG) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
Medium
Report
10x Genomics, Inc. (NASDAQ: TXG) had its "sell (e+)" rating re-affirmed by analysts at Weiss Ratings.
3/7
08:10 pm
txg
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program [Yahoo! Finance]
Medium
Report
PacBio Onso™ Short Read Sequencing Instrument Joins 10x Genomics Compatible Partner Program [Yahoo! Finance]
3/4
12:47 pm
txg
10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Citigroup Inc. from $20.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Citigroup Inc. from $20.00 to $15.00. They now have a "buy" rating on the stock.
3/4
08:30 am
txg
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products [Yahoo! Finance]
High
Report
Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products [Yahoo! Finance]
3/3
04:40 pm
txg
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products [Yahoo! Finance]
Medium
Report
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products [Yahoo! Finance]
3/3
04:05 pm
txg
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
Medium
Report
10x Genomics Secures Injunction Against Parse Biosciences' Planned ATAC Products
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
05:36 pm
txg
Form 4 10x Genomics, Inc. For: Mar 17 Filed by: Saxonov Serge
Medium
Report
Form 4 10x Genomics, Inc. For: Mar 17 Filed by: Saxonov Serge
3/19
05:35 pm
txg
Form 4 10x Genomics, Inc. For: Mar 17 Filed by: Hindson Benjamin J.
Medium
Report
Form 4 10x Genomics, Inc. For: Mar 17 Filed by: Hindson Benjamin J.
3/19
05:34 pm
txg
Form 4 10x Genomics, Inc. For: Oct 23 Filed by: Taich Adam
Medium
Report
Form 4 10x Genomics, Inc. For: Oct 23 Filed by: Taich Adam
3/4
06:50 pm
txg
Form 4 10x Genomics, Inc. For: Feb 28 Filed by: Saxonov Serge
Low
Report
Form 4 10x Genomics, Inc. For: Feb 28 Filed by: Saxonov Serge
2/28
05:04 pm
txg
Form 144 10x Genomics, Inc. Filed by: Saxonov Serge
Medium
Report
Form 144 10x Genomics, Inc. Filed by: Saxonov Serge
2/26
05:43 pm
txg
Form 4 10x Genomics, Inc. For: Feb 24 Filed by: Saxonov Serge
Medium
Report
Form 4 10x Genomics, Inc. For: Feb 24 Filed by: Saxonov Serge
2/26
05:43 pm
txg
Form 4 10x Genomics, Inc. For: Feb 24 Filed by: Hindson Benjamin J.
Medium
Report
Form 4 10x Genomics, Inc. For: Feb 24 Filed by: Hindson Benjamin J.
2/25
05:22 pm
txg
Form 4 10x Genomics, Inc. For: Feb 21 Filed by: MATEO ALAN
Low
Report
Form 4 10x Genomics, Inc. For: Feb 21 Filed by: MATEO ALAN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
12/19
Form 8-K 10x Genomics, Inc. For: Dec 18
19.6%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
2/27 Form 10-K 10x Genomics, Inc. For: Dec 31 9.6%
9/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: Paladin Capital Cyber Group, LLC 8.8%
11/9 10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript [The Motley Fool] 8.2%
3/9 Form 4 10x Genomics, Inc. For: Mar 06 Filed by: CRUTCHFIELD BRADFORD 7.3%
10/25 10x Genomics to Report Third Quarter 2019 Financial Results on November 7, 2019 6.8%
12/20 10x Genomics and Care.com among Tech gainers; CalAmp and Technical Communications among losers [Seeking Alpha] 6.8%
2/14 Form 8-K 10x Genomics, Inc. For: Feb 12 6.7%
4/3 Form 4 10x Genomics, Inc. For: Apr 01 Filed by: CRUTCHFIELD BRADFORD 6.1%
4/7 Form 4 10x Genomics, Inc. For: Apr 06 Filed by: Saxonov Serge 5.7%
TOP News Decliners
9/24
10x Genomics (NYSE: TXG) is now covered by analysts at Evercore ISI. They set an "outperform" rating on the stock.
-10.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
2/25 10x Genomics to Present at the 40th Annual Cowen Health Care Conference -8.0%
1/30 The Daily Biotech Pulse: Novartis Earnings, Hepion's NASH Candidate Beats Rival Drugs, Annovis Bio To Debut [Yahoo! Finance News] -7.4%
3/5 10x Genomics (NYSE: TXG) is now covered by analysts at Guggenheim. They set a "buy" rating on the stock. -6.2%
12/11 Form 8-K 10x Genomics, Inc. For: Dec 11 -5.6%
3/18 Form 3 10x Genomics, Inc. For: Sep 11 Filed by: SOFTBANK VISION FUND (AIV M2) L.P. -5.2%
12/12 Form 8-K 10x Genomics, Inc. For: Dec 12 -4.7%
9/12 Form 4 10x Genomics, Inc. For: Sep 11 Filed by: ROBERTS BRYAN E -4.1%
1/7 10x Genomics to Present at the 38th Annual J.P. Morgan Healthcare Conference -3.3%
11/26 10x Genomics Begins Shipments of Visium Spatial Gene Expression Solution -3.0%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: